Observations placeholder
Nuedexta
Identifier
019724
Type of Spiritual Experience
Background
Pseudobulbar affect (PBA), emotional lability, labile affect, or emotional incontinence refers to a neurologic disorder characterized by involuntary crying or uncontrollable episodes of crying and/or laughing, or other emotional displays. PBA occurs secondary to a neurologic disease or brain injury.
A description of the experience
Dextromethorphan/quinidine (trade name Nuedexta) is a combination drug containing dextromethorphan and the class I antiarrhythmic agent quinidine. It is the first FDA-approved drug for the treatment of pseudobulbar affect (PBA).
Adverse effects
Common risks and side effects include:
- Abdominal pain
- Asthenia
- Cough
- Diarrhea (reported in 13% of patients)
- Dizziness
- Elevated gamma glutamyltransferase
- Flatulence
- Influenza
- Prolonged QT interval
- Muscle spasm
- Peripheral edema
- Urinary tract infection
- Vomiting
On Jan, 04, 2017 893 people reported to have side effects when taking Nuedexta.
Among them, 17 people (1.9%) have Hallucination
On Jan, 21, 2016: 76 people reported to have side effects when taking Nuedexta. Among them, 7 people (9.21%) have Death.
Time on Nuedexta when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |